Analyzing non-sentinel axillary metastases in patients with T3-T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy

In the ACOSOG Z0011 trial, completing axillary lymph node dissection (cALND) did not benefit patients with T1-T2 cN0 early breast cancer and 1-2 positive sentinel lymph nodes (SLN) undergoing breast-conserving surgery (BCT). This paper reports cALND rates in the clinical routine for patients who had...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Riedel, Fabian (VerfasserIn) , Heil, Jörg (VerfasserIn) , Feißt, Manuel (VerfasserIn) , Moderow, Mareike (VerfasserIn) , Au, Alexandra von (VerfasserIn) , Domschke, Christoph (VerfasserIn) , Michel, Laura L. (VerfasserIn) , Schäfgen, Benedikt (VerfasserIn) , Golatta, Michael (VerfasserIn) , Hennigs, André (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 20 August 2020
In: Breast cancer research and treatment
Year: 2020, Jahrgang: 184, Heft: 2, Pages: 627-636
ISSN:1573-7217
DOI:10.1007/s10549-020-05876-z
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s10549-020-05876-z
Volltext
Verfasserangaben:Fabian Riedel, Joerg Heil, Manuel Feisst, Mareike Moderow, Alexandra von Au, Christoph Domschke, Laura Michel, Benedikt Schaefgen, Michael Golatta, André Hennigs
Beschreibung
Zusammenfassung:In the ACOSOG Z0011 trial, completing axillary lymph node dissection (cALND) did not benefit patients with T1-T2 cN0 early breast cancer and 1-2 positive sentinel lymph nodes (SLN) undergoing breast-conserving surgery (BCT). This paper reports cALND rates in the clinical routine for patients who had higher (T3-T4) tumor stages and/or underwent mastectomy but otherwise met the ACOSOG Z0011 eligibility criteria. Aim of this study is to determine cALND time trends and non-sentinel axillary metastases (NSAM) rates to estimate occult axillary tumor burden.
Beschreibung:Gesehen am 12.08.2021
Beschreibung:Online Resource
ISSN:1573-7217
DOI:10.1007/s10549-020-05876-z